PHARMACOLOGICAL CHARACTERIZATION OF A HISTONE DEACETYLASE INHIBITOR AND TUMOR CELL-GROWTH INHIBITION PROPERTIES OF NEW BENZOFURANONE COMPOUNDS

被引：0

作者：

Blanquart, Christophe ^{[1
]}

Francois, Manon ^{[1
]}

Charrier, Cedric ^{[2
]}

Bertrand, Philippe ^{[2
]}

Gregoire, Marc ^{[1
]}

机构：

[1] INSERM, U892, F-75654 Paris 13, France

[2] CNRS, Umr 6514, F-75700 Paris, France

来源：

JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期

关键词：

Cancer; HDAC inhibitors; BRET;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S924 / S924

页数：1

共 50 条

[31] Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells
Attoub, Samir
Hassan, Ahmed H.
Vanhoecke, Barbara
Iratni, Rabah
Takahashi, Takashi
Gaben, Anne-Marie
Bracke, Marc
Awad, Salma
John, Anne
Kamalboor, Hamda Ahmed
Al Sultan, Mahmood Ahmed
Arafat, Kholoud
Gespach, Christian
Petroianu, Georg
EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 651 (1-3) : 18 - 25
[32] Cleavage of HSP90β induced by histone deacetylase inhibitor and proteasome inhibitor modulates cell growth and apoptosis
Park, Sangkyu
Jeon, Jae-Hyung
Park, Jeong-A
Choi, Jun-Kyu
Lee, Younghee
CELL STRESS & CHAPERONES, 2021, 26 (01): : 129 - 139
[33] Cleavage of HSP90β induced by histone deacetylase inhibitor and proteasome inhibitor modulates cell growth and apoptosis
Sangkyu Park
Jae-Hyung Jeon
Jeong-A Park
Jun-Kyu Choi
Younghee Lee
Cell Stress and Chaperones, 2021, 26 : 129 - 139
[34] Pharmacological targeting of TNS3 with histone deacetylase inhibitor as a therapeutic strategy in esophageal squamous cell carcinoma
Shi, Yang
Xiang, Zheng
Yang, Huiyu
Khan, Suliman
Li, Ruizhe
Zhou, Siran
Ullah, Saif
Zhang, Jiyu
Liu, Bingrong
AGING-US, 2021, 13 (11): : 15336 - 15352
[35] The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
Kornelius Kerl
David Ries
Rebecca Unland
Christiane Borchert
Natalia Moreno
Martin Hasselblatt
Heribert Jürgens
Marcel Kool
Dennis Görlich
Maria Eveslage
Manfred Jung
Michael Meisterernst
Michael Frühwald
BMC Cancer, 13
[36] The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
Kerl, Kornelius
Ries, David
Unland, Rebecca
Borchert, Christiane
Moreno, Natalia
Hasselblatt, Martin
Jurgens, Heribert
Kool, Marcel
Gorlich, Dennis
Eveslage, Maria
Jung, Manfred
Meisterernst, Michael
Fruhwald, Michael
BMC CANCER, 2013, 13
[37] The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances gemcitabine-induced cell death in pancreatic cancer
Arnold, Nichole Boyer
Arkus, Nolhea
Gunn, Jason
Korc, Murray
CLINICAL CANCER RESEARCH, 2007, 13 (01) : 18 - 26
[38] The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer
Shi, Yi-kang
Li, Zhong-hua
Han, Xi-qian
Yi, Ji-hu
Wang, Zhen-hua
Hou, Jing-li
Feng, Cong-ran
Fang, Qing-hong
Wang, Hui-hui
Zhang, Peng-fei
Wang, Feng-shan
Shen, Jie
Wang, Peng
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (06) : 1131 - 1140
[39] The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer
Yi-kang Shi
Zhong-hua Li
Xi-qian Han
Ji-hu Yi
Zhen-hua Wang
Jing-li Hou
Cong-ran Feng
Qing-hong Fang
Hui-hui Wang
Peng-fei Zhang
Feng-shan Wang
Jie Shen
Peng Wang
Cancer Chemotherapy and Pharmacology, 2010, 66 : 1131 - 1140
[40] STIMULATION AND INHIBITION OF NEOPLASTIC CELL-GROWTH BY TUMOR PROMOTER-TREATED MACROPHAGES
SCHULTZ, RM
CHIRIGOS, MA
OLKOWSKI, ZL
CELLULAR IMMUNOLOGY, 1980, 54 (01) : 98 - 106

← 1 2 3 4 5 →